Halozyme Therapeutics (HALO) Tops Q3 EPS by 31c, provides guidance

Go back to Halozyme Therapeutics (HALO) Tops Q3 EPS by 31c, provides guidance
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 109.68 +1.24 (1.14%)
Previous Close $108.44    52 Week High $18.39 
Open $107.08    52 Week Low $6.96 
Day High $110.88    P/E N/A 
Day Low $106.82    EPS $-0.58 
Volume 1,983,629